F. Cheng

发表

Secretome profiling identifies neuron-derived neurotrophic factor as a tumor-suppressive factor in lung cancer.

Weiqun Peng, Yan Kai, A. Tzatsos, 2019, JCI insight.

Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer.

Bin Yu, D. Gabrilovich, E. Sotomayor, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Expansion of Myeloid Suppressor Cells in SHIP-Deficient Mice Represses Allogeneic T Cell Responses1

C. Desponts, W. Kerr, J. Brayer, 2004, The Journal of Immunology.

All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination.

Bin Yu, D. Gabrilovich, E. Sotomayor, 2003, Cancer research.

Identification of a novel negative role of flagellin in regulating IL‐10 production

Hong Wang, Hong-Gang Wang, E. Sotomayor, 2007, European journal of immunology.

Author Correction: Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells

N. Lee, J. Pinilla-Ibarz, A. Kozikowski, 2019, Scientific Reports.

Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells

N. Lee, J. Pinilla-Ibarz, A. Kozikowski, 2019, Scientific Reports.

Essential role of HDAC6 in the regulation of PD‐L1 in melanoma

K. Smalley, E. Seto, M. Montecino, 2016 .

Macrophages through Transcriptional Augments Inflammatory Responses in Histone Deacetylase Inhibitor LAQ824

K. Bhalla, K. Wright, E. Seto, 2017 .

Immune tolerance in breast cancer.

D. Gabrilovich, E. Sotomayor, F. Cheng, 2004, Breast disease.

A Novel Role for Histone Deacetylase 6 in the Regulation of the Tolerogenic STAT3/IL-10 Pathway in APCs

David M. Woods, D. Woods, E. Seto, 2014, The Journal of Immunology.

The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity

David M. Woods, P. Atadja, D. Woods, 2013, Melanoma research.

TLR5 ligation by flagellin converts tolerogenic dendritic cells into activating antigen-presenting cells that preferentially induce T-helper 1 responses.

J. Brayer, E. Sotomayor, F. Cheng, 2009, Immunology letters.

Pathway in APCs Regulation of the Tolerogenic STAT3/IL-10 A Novel Role for Histone Deacetylase 6 in the

D. Woods, E. Seto, J. Tao, 2014 .

Divergent roles of histone deacetylase 6 (HDAC6) and histone deacetylase 11 (HDAC11) on the transcriptional regulation of IL10 in antigen presenting cells.

D. Woods, E. Seto, J. Pinilla-Ibarz, 2014, Molecular immunology.

In vivo disruption of tolerogenic cross-presentation mechanisms uncovers an effective T-cell activation by B-cell lymphomas leading to antitumor immunity.

A. Cuenca, Hong-wei Wang, J. Brayer, 2006, Blood.

Methyltransferase‐like 3 promotes the progression of lung cancer via activating PI3K/AKT/mTOR pathway

F. Cheng, D. Luo, Lifen Peng, 2022, Clinical and experimental pharmacology & physiology.

Enhanced CD8 T cell cross-presentation by macrophages with targeted disruption of STAT3.

J. Pinilla-Ibarz, J. Brayer, Hongwei Wang, 2010, Immunology letters.

HDAC11 regulates expression of C/EBPβ and immunosuppressive molecules in myeloid‐derived suppressor cells

E. Seto, J. Pinilla-Ibarz, J. Tao, 2021, Journal of leukocyte biology.

Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: dominant role of cross-tolerance to tumor antigens.

A. Cuenca, H. Bien, J. Brayer, 2003, Cancer research.

Epigenetic Modulation of STAT3 by Histone Deacetylase 6 (HDAC6) Regulates IL-10 Gene Expression and Immune Tolerance Mediated by Antigen-Presenting Cells (APCs)

E. Seto, Hongwei Wang, W. Hancock, 2011 .

Histone Deacetylase Inhibitor LAQ824 Augments Inflammatory Responses in Macrophages through Transcriptional Regulation of IL-10

K. Bhalla, K. Wright, E. Seto, 2011, The Journal of Immunology.

Essential role for histone deacetylase 11 (HDAC11) in neutrophil biology

Sheng Wei, E. Seto, J. Pinilla-Ibarz, 2017, Journal of leukocyte biology.

A critical role for Stat3 signaling in immune tolerance.

Hua Yu, Shizuo Akira, S. Akira, 2003, Immunity.

The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance

P. Atadja, K. Bhalla, K. Wright, 2009, Nature Immunology.

A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas.

J. Bradner, W. Dalton, L. Moscinski, 2013, The Journal of clinical investigation.

T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine model.

D. Woods, E. Seto, J. Pinilla-Ibarz, 2017, Blood.

BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models.

K. Fu, Mousheng Xu, A. Silva, 2019, Cancer cell.

Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and function.

David M. Woods, D. Woods, J. Pinilla-Ibarz, 2015, Molecular immunology.

Stat3 inhibition augments the immunogenicity of B-cell lymphoma cells, leading to effective antitumor immunity.

S. Sebti, J. Pinilla-Ibarz, J. Tao, 2012, Cancer research.

Loss of HDAC11 ameliorates clinical symptoms in a multiple sclerosis mouse model

E. Seto, Robert H Miller, E. Sotomayor, 2018, Life Science Alliance.

Combination therapy with AG-490 and interleukin 12 achieves greater antitumor effects than either agent alone.

D. Coppola, Hua Yu, R. Jove, 2002, Molecular cancer therapeutics.

Targeting histone deacetylase 6 mediates a dual anti‐melanoma effect: Enhanced antitumor immunity and impaired cell proliferation

David M. Woods, D. Woods, K. Smalley, 2015, Molecular oncology.

Imatinib mesylate (STI-571) enhances antigen-presenting cell function and overcomes tumor-induced CD4+ T-cell tolerance.

A. Cuenca, K. Bhalla, Hongwei Wang, 2005, Blood.

Cold Plasma with Immunomodulatory Properties Has Significant Anti-Lymphoma Activities in Vitro and In Vivo

M. Keidar, E. Sotomayor, F. Cheng, 2019, Blood.

T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine model.

David M. Woods, E. Seto, J. Pinilla-Ibarz, 2017, Blood.

Regulation of IL-10 Macrophages through Transcriptional Augments Inflammatory Responses in Histone Deacetylase Inhibitor LAQ824

K. Bhalla, K. Wright, E. Seto, 2011 .